University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)

北卡罗来纳大学艾滋病临床试验中心 (UNC ACTU)

• 批准号: 7900104
• 负责人: Joseph J Eron
• 金额: $ 303.68万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-08-13 至 2011-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7900104
• 关键词: AIDS prevention; Acquired Immunodeficiency Syndrome; Address; Adult; Affect; Area; Clinical Management; Clinical Research; Clinical Trials; Clinical Trials Cooperative Group; Clinical Trials Unit; Country; County; Data Quality; Enrollment; Funding; HIV; HIV Infections; HIV Vaccine Trials Network; HIV prevention trials network; HIV vaccine; Health; Health Sciences; Hospitals; Human; Leadership; Morbidity - disease rate; North Carolina; Population; Prevention; Prevention strategy; Protocols documentation; Recruitment Activity; Research; Research Personnel; Research Priority; Resources; Retinal Cone; Services; Site; Structure; Training; Translational Research; Underserved Population; Universities; clinical research site; data management; drug development; experience; flexibility; forest; improved; outreach; vaccine development

DESCRIPTION (provided by applicant): This application proposes to establish the UNC-Chapel Hill Clinical Trials Unit (UNC-CH CTU) and its attendant clinical sites at UNC Chapel Hill, UNC Wake County Health and Human Services, Moses Cone Hospital, and Wake Forest University Health Sciences. This pluripotential unit and sites propose to efficiently recruit, enroll and retain subjects on protocols affiliated with three NIH-funded multi-center clinical research groups; Adult Aids Clinical Trials Group (ACTG), HIV Prevention Trials Network (HPTN), and HIV Vaccine Trials Network (HVTN) that will address four NIH/DAIDS clinical research priority areas: 1) Translational Research and Drug Development (ACTG), 2) Optimization of Clinical Management, including Co-morbidities (ACTG), 3) Prevention of HIV Infection (HPTN), and 4) HIV Vaccines (HVTN). The UNC-CH CTU and the four clinical research sites have extensive experience in HIV-related clinical trials including participation in the ACTS for 18 years as one of the premier units in that organization. The leadership of the Unit and Sites has the appropriate expertise to conduct these trials and to maximize the scientific opportunities by integrating this robust expertise in the 4 high priority research areas. The structure of the UNC-CH CTU and sites allows for flexible and responsive clinical research that will build and strengthen research capacity focusing on underserved populations in the Southeastern US, serving the population most affected by HIV in our country. Our Structure maximizes efficiency by sharing key resources amongst priority areas including investigators, sites and unit staff, training, protocol implementation, management, regulatory services, outreach, recruitment, and data management and data quality. The UNC CTU and its four Clinical Research Sites will improve the treatment of HIV and decrease HIV spread by contributing to HIV prevention strategies and HIV vaccine development. ADMINISTRATIVE COMPONENT:

描述（由申请人提供）： 本申请拟在北查佩尔山、维克县卫生与公众服务部、摩西锥医院和维克森林大学健康科学部建立UNC-查佩尔山临床试验单位（UNC-CH CTU）及其附属临床研究中心。这个多能单位和研究中心建议有效地招募，招募和保留隶属于三个NIH资助的多中心临床研究小组的方案的受试者;成人艾滋病临床试验组（ACTG），HIV预防试验网络（HPTN）和HIV疫苗试验网络（HVTN）将解决四个NIH/DAIDS临床研究优先领域：1）转化研究和药物开发（ACTG），2）优化临床管理，包括合并症（ACTG），3）预防HIV感染（HPTN），4）HIV疫苗（HVTN）。UNC-CH CTU和四个临床研究中心在与艾滋病毒有关的临床试验方面拥有丰富的经验，包括作为该组织的主要单位之一参加了18年的临床试验。该部门和研究中心的领导层拥有开展这些试验的适当专业知识，并通过将这一强大的专业知识整合到4个高优先级研究领域中来最大限度地利用科学机会。UNC-CH CTU和站点的结构允许灵活和响应的临床研究，将建立和加强研究能力，重点关注美国东南部服务不足的人群，为我国受艾滋病毒影响最严重的人群提供服务。我们的结构通过在优先领域共享关键资源来最大限度地提高效率，这些优先领域包括研究者、研究中心和单位工作人员、培训、方案实施、管理、监管服务、外展、招聘以及数据管理和数据质量。该联合会及其四个临床研究中心将通过促进艾滋病毒预防战略和艾滋病毒疫苗的开发，改善艾滋病毒的治疗，减少艾滋病毒的传播。 行政部门：